exv4w3



 





Exhibit 4.3




OMEROS CORPORATION




AMENDED AND RESTATED

INVESTORS’ RIGHTS AGREEMENT




October 15, 2004




 









 





TABLE OF CONTENTS




	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page	 
	 
	 	 	 	 	 	 	 	 
	1.
	 	Registration Rights	 	 	2	 
	 
	 	1.1	 	Definitions	 	 	2	 
	 
	 	1.2	 	Request for Registration	 	 	3	 
	 
	 	1.3	 	Company Registration	 	 	4	 
	 
	 	1.4	 	Form S-3 Registration	 	 	4	 
	 
	 	1.5	 	Obligations of the Company	 	 	5	 
	 
	 	1.6	 	Furnish Information	 	 	7	 
	 
	 	1.7	 	Expenses of Registration	 	 	7	 
	 
	 	1.8	 	Underwriting Requirements	 	 	8	 
	 
	 	1.9	 	Delay of Registration	 	 	9	 
	 
	 	1.10	 	Indemnification	 	 	9	 
	 
	 	1.11	 	Reports Under Securities Exchange Act of 1934	 	 	11	 
	 
	 	1.12	 	Assignment of Registration Rights	 	 	11	 
	 
	 	1.13	 	Limitations on Subsequent Registration Rights	 	 	12	 
	 
	 	1.14	 	Market Stand-Off Agreement	 	 	12	 
	 
	 	1.15	 	Termination of Registration Rights	 	 	13	 
	2.
	 	Covenants of the Company	 	 	13	 
	 
	 	2.1	 	Delivery of Financial Statements	 	 	13	 
	 
	 	2.2	 	Inspection	 	 	13	 
	 
	 	2.3	 	Right of First Offer	 	 	14	 
	 
	 	2.4	 	Termination of Covenants	 	 	15	 
	3.
	 	Restrictions on Transfer	 	 	16	 
	 
	 	3.1	 	Notice of Sales; Right of First Refusal	 	 	16	 
	 
	 	3.2	 	Failure to Exercise	 	 	17	 
	 
	 	3.3	 	No Transfers without Board Approval	 	 	17	 
	 
	 	3.4	 	Permitted Transactions	 	 	17	 
	 
	 	3.5	 	Prohibited Transfers	 	 	18	 
	 
	 	3.6	 	Legended Certificates	 	 	18	 
	 
	 	3.7	 	Termination	 	 	18	 
	4.
	 	Miscellaneous	 	 	19	 
	 
	 	4.1	 	Successors and Assigns	 	 	19	 
	 
	 	4.2	 	Amendments and Waivers	 	 	19	 
	 
	 	4.3	 	Notices	 	 	19	 
	 
	 	4.4	 	Severability	 	 	19	 
	 
	 	4.5	 	Governing Law	 	 	20	 
	 
	 	4.6	 	Counterparts	 	 	20	 
	 
	 	4.7	 	Titles and Subtitles	 	 	20	 
	 
	 	4.8	 	Aggregation of Stock	 	 	20	 
	 
	 	4.9	 	Entire Agreement	 	 	20	 
	 
	 	4.10	 	Telecopy Execution and Delivery	 	 	20	 
	 
	 	4.11	 	Arbitration	 	 	20	 
	 
	 	4.12	 	Termination and Supersession	 	 	21	 







-i-









 








OMEROS CORPORATION




AMENDED AND RESTATED

INVESTORS’ RIGHTS AGREEMENT




     This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of
the 15th day of October, 2004 by and among Omeros Corporation, a Washington corporation
(the “Company”), the investors listed on Exhibit A hereto (the “Series E
Investors”), H. Raymond Cairncross, Gregory A. Demopulos, M.D., George Kargianis, and Pamela
Pierce Palmer, M.D., Ph.D., each of whom is herein referred to as a “Founder,” the holders
of Series A Preferred Stock of the Company (the “Series A Preferred Stock”) listed on
Exhibit B hereto (the “Series A Investors”), the holders of Series B Preferred
Stock of the Company (the “Series B Preferred Stock”) listed on Exhibit C hereto
(the “Series B Investors”), the holders of Series C Preferred Stock of the Company (the
“Series C Preferred Stock”) listed on Exhibit D hereto (the “Series C
Investors”), the holders of the Series D Preferred Stock of the Company (the “Series D
Preferred Stock”) listed on Exhibit E hereto (the “Series D Investors,” and
together with the Series A Investors, the Series B Investors, the Series C Investors and the Series
E Investors, the “Investors”), and the holders of Common Stock of the Company (the
“Common Stock”) listed on Exhibit F hereto (the “Common Shareholders”).



RECITALS




     The Company, the Founders, the Common Shareholders and the Investors are parties to the
Amended and Restated Investors’ Rights Agreement dated as of March 16, 2004, as amended on March
19, 2004 (the “Prior Agreement”). The Company issued and sold to the Series E Investors
shares of its Series E Preferred Stock pursuant to the Series E Preferred Stock Purchase Agreement
(the “Purchase Agreement”) dated March 16, 2004 and Addendum Agreements thereto. A
condition to the Series E Investors’ obligations under the Purchase Agreement and the Addendum
Agreements thereto was that the Company, the Founders, the Common Shareholders and the Investors
enter into the Prior Agreement in order to provide the Investors with (i) certain rights to
register shares of Common Stock issuable upon conversion of the Preferred Stock held by the
Investors, (ii) certain rights to receive or inspect information pertaining to the Company, (iii) a
right of first offer with respect to certain issuances by the Company of its securities and (iv) a
right of first refusal upon proposed sales of the Company’s securities held by the Investors and
the Common Shareholders. The Company, the Investors, the Founders and the Common Shareholders each
desire to amend and restate the Prior Agreement in its entirety as set forth herein in order to,
among other things, provide certain of such rights to additional Investors.



 









 





AGREEMENT




     The parties hereby agree as follows:



     1. Registration Rights. The Company and the Investors covenant and agree as follows:



          1.1 Definitions. For purposes of this Section 1:




               (a) The terms “register,” “registered,” and “registration” refer to a
registration effected by preparing and filing a registration statement or similar document in
compliance with the Securities Act of 1933, as amended (the “Securities Act”), and the
declaration or ordering of effectiveness of such registration statement or document;



               (b) The term “Registrable Securities” means (i) the shares of Common Stock issuable or
issued upon conversion of the Series A, Series B, Series C, Series D and Series E Preferred Stock,
(ii) the shares of Common Stock issued to the Founders (the “Founders’ Stock”),
provided, however, that for the purposes of Section 1.2, 1.4 and 1.13 the Founders’
Stock shall not be deemed Registrable Securities and the Founders shall not be deemed Holders, and
(iii) any other shares of Common Stock of the Company issued as (or issuable upon the conversion or
exercise of any warrant, right or other security which is issued as) a dividend or other
distribution with respect to, or in exchange for or in replacement of, the shares listed in (i) and
(ii); provided, however, that the foregoing definition shall exclude in all cases
any Registrable Securities sold by a person in a transaction in which his or her rights under this
Agreement are not assigned. Notwithstanding the foregoing, Common Stock or other securities shall
only be treated as Registrable Securities if and so long as they have not been (A) sold to or
through a broker or dealer or underwriter in a public distribution or a public securities
transaction, or (B) sold in a transaction exempt from the registration and prospectus delivery
requirements of the Securities Act under Section 4(1) thereof so that all transfer restrictions,
and restrictive legends with respect thereto, if any, are removed upon the consummation of such
sale;



               (c) The number of shares of “Registrable Securities then outstanding” shall be
determined by the number of shares of Common Stock outstanding which are, and the number of shares
of Common Stock issuable pursuant to then exercisable or convertible securities which are,
Registrable Securities;



               (d) The term “Holder” means any person owning or having the right to acquire
Registrable Securities or any assignee thereof in accordance with Section 1.12 of this Agreement;



               (e) The term “Form S-3” means such form under the Securities Act as in effect on the
date hereof or any successor form under the Securities Act;



               (f) The term “SEC” means the Securities and Exchange Commission; and



-2-









 





               (g) The term “Qualified IPO” means a firm commitment underwritten public offering by
the Company of shares of its Common Stock pursuant to a registration statement under the Securities
Act, which results in aggregate gross proceeds to the Company of at least $10,000,000.



          1.2 Request for Registration.




               (a) If the Company shall receive at any time after the earlier of (i) three (3) years after
the Closing (as defined in the Purchase Agreement) or (ii) six (6) months after the effective date
of the first registration statement for a public offering of securities of the Company (other than
a registration statement relating either to the sale of securities to employees of the Company
pursuant to a stock option, stock purchase or similar plan or an SEC Rule 145 transaction), a
written request from the Holders of at least thirty percent (30%) of the Registrable Securities
then outstanding that the Company file a registration statement under the Securities Act covering
the registration of Registrable Securities with an anticipated aggregate gross offering price in
excess of $10,000,000, then the Company shall, within ten (10) days of the receipt thereof, give
written notice of such request to all Holders and shall, subject to the limitations of subsection
1.2(b), use its best efforts to effect as soon as practicable, and in any event within 60 days of
the receipt of such request, the registration under the Securities Act of all Registrable
Securities which the Holders request to be registered within twenty (20) days of the mailing of
such notice by the Company in accordance with Section 4.3.



               (b) If the Holders initiating the registration request hereunder (“Initiating
Holders”) intend to distribute the Registrable Securities covered by their request by means of
an underwriting, they shall so advise the Company as a part of their request made pursuant to this
Section 1.2 and the Company shall include such information in the written notice referred to in
subsection 1.2(a). The underwriter will be selected by a majority in interest of the Initiating
Holders and shall be reasonably acceptable to the Company. In such event, the right of any Holder
to include his Registrable Securities in such registration shall be conditioned upon such Holder’s
participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the
underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders
and such Holder) to the extent provided herein. All Holders proposing to distribute their
securities through such underwriting shall (together with the Company as provided in subsection
1.5(e)) enter into an underwriting agreement in customary form with the underwriter or underwriters
selected for such underwriting. Notwithstanding any other provision of this Section 1.2, if the
underwriter advises the Initiating Holders in writing that marketing factors require a limitation
of the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders
of Registrable Securities which would otherwise be underwritten pursuant hereto, and the number of
shares of Registrable Securities that may be included in the underwriting shall be allocated among
all Holders thereof, including the Initiating Holders, in proportion (as nearly as practicable) to
the amount of Registrable Securities of the Company owned by each Holder; provided,
however, that the number of shares of Registrable Securities to be included in such
underwriting shall not be reduced unless all other securities are first entirely excluded from the
underwriting.



-3-









 





               (c) Notwithstanding the foregoing, if the Company shall furnish to Holders requesting a
registration statement pursuant to this Section 1.2 a certificate signed by the President of the
Company stating that in the good faith judgment of the Board of Directors of the Company, it would
be seriously detrimental to the Company and its shareholders for such registration statement to be
filed and it is therefore essential to defer the filing of such registration statement, the Company
shall have the right to defer such filing for a period of not more than 120 days after receipt of
the request of the Initiating Holders; provided, however, that the Company may not
utilize this right more than once in any twelve-month period.



               (d) In addition, the Company shall not be obligated to effect, or to take any action to
effect, any registration pursuant to this Section 1.2:



                    (i) After the Company has effected one (1) registration pursuant to this Section 1.2 and such
registration has been declared or ordered effective;



                    (ii) During the period starting with the date sixty (60) days prior to the Company’s good
faith estimate of the date of filing of, and ending on a date one hundred eighty (180) days after
the effective date of, a registration subject to Section 1.3 hereof; provided that the
Company is actively employing in good faith all reasonable efforts to cause such registration
statement to become effective; or



                    (iii) If the Initiating Holders propose to dispose of shares of Registrable Securities that
may be immediately registered on Form S-3 pursuant to a request made pursuant to Section 1.4 below.



          1.3 Company Registration. If (but without any obligation to do so) the Company
proposes to register (including for this purpose a registration effected by the Company for
shareholders other than the Holders) any of its stock under the Securities Act in connection with
the public offering of such securities solely for cash (other than a registration relating solely
to the sale of securities to participants in a Company stock plan or a transaction covered by Rule
145 under the Securities Act, a registration in which the only stock being registered is Common
Stock issuable upon conversion of debt securities which are also being registered, or any
registration on any form which does not include substantially the same information as would be
required to be included in a registration statement covering the sale of the Registrable
Securities), the Company shall, at such time, promptly give each Holder written notice of such
registration. Upon the written request of each Holder given within twenty (20) days after mailing
of such notice by the Company in accordance with Section 4.3, the Company shall, subject to the
provisions of Section 1.8, cause to be registered under the Securities Act all of the Registrable
Securities that each such Holder has requested to be registered.




          1.4 Form S-3 Registration. In case the Company shall receive from any Holder or
Holders of not less than twenty percent (20%) of the Registrable Securities then outstanding a
written request or requests that the Company effect a registration on Form S-3 and
any related qualification or compliance with respect to all or a part of the Registrable
Securities owned by such Holder or Holders, the Company will:





-4-









 








               (a) promptly give written notice of the proposed registration, and any related qualification
or compliance, to all other Holders; and



               (b) as soon as practicable, effect such registration and all such qualifications and
compliances as may be so requested and as would permit or facilitate the sale and distribution of
all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such
request, together with all or such portion of the Registrable Securities of any other Holder or
Holders joining in such request as are specified in a written request given within 15 days after
receipt of such written notice from the Company; provided, however, that the
Company shall not be obligated to effect any such registration, qualification or compliance,
pursuant to this Section 1.4: (i) if Form S-3 is not available for such offering by the Holders;
(ii) if the Holders, together with the holders of any other securities of the Company entitled to
inclusion in such registration, propose to sell Registrable Securities and such other securities
(if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of
less than $2,500,000; (iii) if the Company shall furnish to the Holders a certificate signed by the
President of the Company stating that in the good faith judgment of the Board of Directors of the
Company, it would be seriously detrimental to the Company and its shareholders for such Form S-3
Registration to be effected at such time, in which event the Company shall have the right to defer
the filing of the Form S-3 registration statement for a period of not more than 120 days after
receipt of the request of the Holder or Holders under this Section 1.4; provided,
however, that the Company shall not utilize this right more than once in any twelve month
period; (iv) if the Company has, within the twelve (12) month period preceding the date of such
request, already effected one (1) registration on Form S-3 for the Holders pursuant to this Section
1.4; (v) in any particular jurisdiction in which the Company would be required to qualify to do
business or to execute a general consent to service of process in effecting such registration,
qualification or compliance; or (vi) during the period ending one hundred eighty (180) days after
the effective date of a registration statement subject to Section 1.3.



               (c) Subject to the foregoing, the Company shall file a registration statement covering the
Registrable Securities and other securities so requested to be registered as soon as practicable
after receipt of the request or requests of the Holders. Registrations effected pursuant to this
Section 1.4 shall not be counted as demands for registration or registrations effected pursuant to
Sections 1.2 or 1.3, respectively.



          1.5 Obligations of the Company. Whenever required under this Section 1 to effect the
registration of any Registrable Securities, the Company shall, as expeditiously as reasonably
possible:




               (a) Prepare and file with the SEC a registration statement with respect to such Registrable
Securities and use its best efforts to cause such registration statement to become effective, and,
upon the request of the Holders of a majority of the Registrable Securities registered thereunder,
keep such registration statement effective for up to one hundred twenty (120) days. The Company shall not be required to file, cause to become effective or maintain
the effectiveness of any registration statement that contemplates a distribution of securities on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act.



-5-









 





               (b) Prepare and file with the SEC such amendments and supplements to such registration
statement and the prospectus used in connection with such registration statement as may be
necessary to comply with the provisions of the Securities Act with respect to the disposition of
all securities covered by such registration statement for up to one hundred twenty (120) days.



               (c) Furnish to the Holders such numbers of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such other documents as
they may reasonably request in order to facilitate the disposition of Registrable Securities owned
by them.



               (d) Use its best efforts to register and qualify the securities covered by such registration
statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably
requested by the Holders; provided that the Company shall not be required in connection
therewith or as a condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions.



               (e) In the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing underwriter of such
offering. Each Holder participating in such underwriting shall also enter into and perform its
obligations under such an agreement.



               (f) Notify each Holder of Registrable Securities covered by such registration statement at any
time when a prospectus relating thereto is required to be delivered under the Securities Act of the
happening of any event as a result of which the prospectus included in such registration statement,
as then in effect, includes an untrue statement of a material fact or omits to state a material
fact required to be stated therein or necessary to make the statements therein not misleading in
the light of the circumstances, such obligation to continue for so long as the Company is obligated
to maintain the effectiveness of such registration statement.



               (g) Cause all such Registrable Securities registered pursuant hereunder to be listed on each
securities exchange on which similar securities issued by the Company are then listed.



               (h) Provide a transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the
effective date of such registration.



               (i) Use its best efforts to furnish, at the request of any Holder requesting registration of
Registrable Securities pursuant to this Section 1, on the date that such Registrable Securities are
delivered to the underwriters for sale in connection with a registration
pursuant to this Section 1, if such securities are being sold through underwriters, or, if
such securities are not being sold through underwriters, on the date that the registration
statement with respect to such securities becomes effective, (i) an opinion, dated such date, of
the counsel representing the Company for the purposes of such registration, in form and substance
as is customarily given to underwriters in an underwritten public offering, addressed to the



-6-









 




underwriters, if any, and to the Holders requesting registration of Registrable Securities and (ii)
a letter dated such date, from the independent certified public accountants of the Company, in form
and substance as is customarily given by independent certified public accountants to underwriters
in an underwritten public offering, addressed to the underwriters, if any, and to the Holders
requesting registration of Registrable Securities.




          1.6 Furnish Information. It shall be a condition precedent to the obligations of the
Company to take any action pursuant to this Section 1 with respect to the Registrable Securities of
any selling Holder that such Holder shall furnish to the Company such information regarding itself,
the Registrable Securities held by it, and the intended method of disposition of such securities as
shall be required to effect the registration of such Holder’s Registrable Securities. The Company
shall have no obligation with respect to any registration requested pursuant to Section 1.2 or
Section 1.4 of this Agreement if, as a result of the application of the preceding sentence, the
number of shares or the anticipated aggregate offering price of the Registrable Securities to be
included in the registration does not equal or exceed the number of shares or the anticipated
aggregate offering price required to originally trigger the Company’s obligation to initiate such
registration as specified in subsection 1.2(a) or subsection 1.4(b)(ii), whichever is applicable.




          1.7 Expenses of Registration.




               (a) Demand Registration. All expenses other than underwriting discounts and
commissions incurred in connection with registrations, filings or qualifications pursuant to
Section 1.2, including (without limitation) all registration, filing and qualification fees,
printers’ and accounting fees, fees and disbursements of counsel for the Company, and the
reasonable fees and disbursements of one counsel for the selling Holders selected by them with the
approval of the Company, which approval shall not be unreasonably withheld, shall be borne by the
Company; provided, however, that the Company shall not be required to pay for any
expenses of any registration proceeding begun pursuant to Section 1.2 if the registration request
is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities
to be registered (in which case all participating Holders shall bear such expenses), unless the
Holders of a majority of the Registrable Securities agree to forfeit their right to one demand
registration pursuant to Section 1.2; provided, however, that if at the time of
such withdrawal, the Holders have learned of a material adverse change in the condition, business,
or prospects of the Company from that known to the Holders at the time of their request and have
withdrawn the request with reasonable promptness following disclosure by the Company of such
material adverse change, then the Holders shall not be required to pay any of such expenses and
shall retain their rights pursuant to Section 1.2.



               (b) Company Registration. All expenses other than underwriting discounts and
commissions incurred in connection with registrations, filings or qualifications of Registrable
Securities pursuant to Section 1.3 for each Holder (which right may be assigned as provided in
Section 1.12), including (without limitation) all registration, filing, and qualification fees,
printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable
fees and disbursements of one counsel for the selling Holder or Holders selected by



-7-









 




them with the approval of the Company, which approval shall not be unreasonably withheld, shall be borne by the
Company.




               (c) Registration on Form S-3. All expenses incurred in connection with a registration
requested pursuant to Section 1.4, including (without limitation) all registration, filing,
qualification, printers’ and accounting fees and the reasonable fees and disbursements of one
counsel for the selling Holder or Holders selected by them with the approval of the Company, which
approval shall not be unreasonably withheld, and counsel for the Company, but not including any
underwriters’ discounts or commissions associated with Registrable Securities, shall be borne by
the Company.



          1.8 Underwriting Requirements. In connection with any offering involving an
underwriting of shares of the Company’s capital stock, the Company shall not be required under
Section 1.3 to include any of the Holders’ securities in such underwriting unless they accept the
terms of the underwriting as agreed upon between the Company and the underwriters selected by it
(or by other persons entitled to select the underwriters), and then only in such quantity as the
underwriters determine in their sole discretion will not jeopardize the success of the offering by
the Company. If the total amount of securities, including Registrable Securities, requested by
shareholders to be included in such offering exceeds the amount of securities sold other than by
the Company that the underwriters determine in their sole discretion is compatible with the success
of the offering, then the Company shall be required to include in the offering only that number of
such securities, including Registrable Securities, which the underwriters determine in their sole
discretion will not jeopardize the success of the offering (the securities so included to be
apportioned pro rata among the selling shareholders according to the total amount of securities
entitled to be included therein owned by each selling shareholder or in such other proportions as
shall mutually be agreed to by such selling shareholders), but in no event shall (i) any shares
being sold by a shareholder exercising a demand registration right similar to that granted in
Section 1.2 be excluded from such offering, (ii) the amount of securities of the selling Holders of
Preferred Stock included in the offering be reduced below thirty percent (30%) of the total amount
of securities included in such offering, unless such offering is the initial public offering of the
Company’s securities, in which case (except as provided in (i) above) the selling shareholders may
be excluded entirely if the underwriters make the determination described above and no other
shareholder’s securities are included or (iii) any securities held by a Founder be included if any
securities held by any selling Holder are excluded. For purposes of the preceding parenthetical
concerning apportionment, for any selling shareholder which is a holder of Registrable Securities
and which is a partnership or corporation, the partners, retired partners and shareholders of such
holder, or the estates and family members of any such partners and retired partners and any trusts
for the benefit of any of the foregoing persons shall be deemed to be a single “selling
shareholder,” and any pro-rata reduction with respect to such “selling shareholder” shall be based upon the aggregate amount of shares carrying registration rights
owned by all entities and individuals included in such “selling shareholder,” as defined in this
sentence.




-8-









 








          1.9 Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any such registration as the result of any controversy
that might arise with respect to the interpretation or implementation of this Section 1.




          1.10 Indemnification. In the event any Registrable Securities are included in a
registration statement under this Section 1:




               (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder,
the partners, officers, directors and shareholders of each Holder, any underwriter (as defined in
the Securities Act) for such Holder and each person, if any, who controls such Holder or
underwriter within the meaning of the Securities Act or the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), against any losses, claims, damages, or liabilities (joint or
several) to which they may become subject under the Securities Act, the Exchange Act or other
federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in
respect thereof) arise out of or are based upon any of the following statements, omissions or
violations (collectively a “Violation”): (i) any untrue statement or alleged untrue
statement of a material fact contained in such registration statement, including any preliminary
prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the
omission or alleged omission to state therein a material fact required to be stated therein, or
necessary to make the statements therein not misleading, or (iii) any violation or alleged
violation by the Company of the Securities Act, the Exchange Act, any state securities law or any
rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities
law; and the Company will pay to each such Holder, underwriter or controlling person, as incurred,
any legal or other expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability, or action; provided, however,
that the indemnity agreement contained in this subsection 1.10(a) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability, or action if such settlement is effected
without the consent of the Company (which consent shall not be unreasonably withheld), nor shall
the Company be liable to any Holder, underwriter, controlling person or other aforementioned person
for any such loss, claim, damage, liability, or action to the extent that it arises out of or is
based upon a Violation which occurs in reliance upon and in conformity with written information
furnished expressly for use in connection with such registration by any such Holder, underwriter,
controlling person or other aforementioned person.



               (b) To the extent permitted by law, each selling Holder will indemnify and hold harmless the
Company, each of its directors, each of its officers who has signed the registration statement,
each person, if any, who controls the Company within the meaning of the Securities Act, any
underwriter, any other Holder selling securities in such registration statement and any controlling
person of any such underwriter or other Holder, against any losses, claims, damages, or liabilities (joint or several) to which any of the foregoing persons may become
subject, under the Securities Act, the Exchange Act or other federal or state law, insofar as such
losses, claims, damages, or liabilities (or actions in respect thereto) arise out of or are based
upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs
in reliance upon and in conformity with written information furnished by such Holder expressly for



-9-









 




use in connection with such registration; and each such Holder will pay, as incurred, any legal or
other expenses reasonably incurred by any person intended to be indemnified pursuant to this
subsection 1.10(b), in connection with investigating or defending any such loss, claim, damage,
liability, or action; provided, however, that the indemnity agreement contained in
this subsection 1.10(b) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent of the Holder, which
consent shall not be unreasonably withheld; provided, that in no event shall any indemnity
under this subsection 1.10(b) exceed the net proceeds from the offering received by such Holder,
except in the case of willful fraud by such Holder.




               (c) Promptly after receipt by an indemnified party under this Section 1.10 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this Section 1.10,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying
party shall have the right to participate in, and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually satisfactory to the parties; provided, however, that an
indemnified party (together with all other indemnified parties which may be represented without
conflict by one counsel) shall have the right to retain one separate counsel, with the reasonable
fees and expenses to be paid by the indemnifying party, if representation of such indemnified party
by the counsel retained by the indemnifying party would be inappropriate due to actual or potential
differing interests between such indemnified party and any other party represented by such counsel
in such proceeding. The failure to deliver written notice to the indemnifying party within a
reasonable time of the commencement of any such action, if prejudicial to its ability to defend
such action, shall relieve such indemnifying party of any liability to the indemnified party under
this Section 1.10, but the omission so to deliver written notice to the indemnifying party will not
relieve it of any liability that it may have to any indemnified party otherwise than under this
Section 1.10.



               (d) If the indemnification provided for in this Section 1.10 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim,
damage or expense referred to therein, then the indemnifying party, in lieu of indemnifying such
indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such loss, liability, claim, damage, or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand and of the
indemnified party on the other in connection with the statements or omissions that resulted in such
loss, liability, claim, damage or expense as well as any other relevant equitable considerations;
provided that in no event shall any contribution by a Holder under this subsection 1.10(d)
exceed the net proceeds from the offering received by such Holder, except in the case of willful
fraud by such Holder. The relative fault of the indemnifying party and of the indemnified party
shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and the parties’
relative intent, knowledge, access to information, and opportunity to correct or prevent such
statement or omission.



-10-









 





               (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the
underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control.



               (f) The obligations of the Company and Holders under this Section 1.10 shall survive the
completion of any offering of Registrable Securities in a registration statement under this Section
1, and otherwise.



          1.11 Reports Under Securities Exchange Act of 1934. With a view to making available
to the Holders the benefits of Rule 144 promulgated under the Securities Act and any other rule or
regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the
public without registration or pursuant to a registration on Form S-3, the Company agrees to:




               (a) make and keep public information available, as those terms are understood and defined in
SEC Rule 144, at all times after ninety (90) days after the effective date of the first
registration statement filed by the Company for the offering of its securities to the general
public so long as the Company remains subject to the periodic reporting requirements under Sections
13 or 15(d) of the Exchange Act;



               (b) take such action, including the voluntary registration of its Common Stock under Section
12 of the Exchange Act, as is necessary to enable the Holders to utilize Form S-3 for the sale of
their Registrable Securities, such action to be taken as soon as practicable after the end of the
fiscal year in which the first registration statement filed by the Company for the offering of its
securities to the general public is declared effective;



               (c) file with the SEC in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act; and



               (d) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith
upon request (i) a written statement by the Company that it has complied with the reporting
requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the
first registration statement filed by the Company), the Securities Act and the Exchange Act (at any
time after it has become subject to such reporting requirements), or that it qualifies as a
registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies),
(ii) a copy of the most recent annual or quarterly report of the Company and such other reports and
documents so filed by the Company, and (iii) such other information as may be reasonably requested
in availing any Holder of any rule or regulation of the SEC which permits the selling of any such
securities without registration or pursuant to such form.



          1.12 Assignment of Registration Rights. The rights to cause the Company to register
Registrable Securities pursuant to this Section 1 may be assigned (but only with all related
obligations) by a Holder to a transferee or assignee of such securities that (i) is a subsidiary,
parent, partner, limited partner, retired partner or shareholder of a Holder; (ii) is a





-11-









 







Holder’s family member or trust for the benefit of an individual Holder; or (iii) after such assignment or
transfer, holds at least 200,000 shares of such securities, provided the Company is, within
a reasonable time after such transfer, furnished with written notice of the name and address of
such transferee or assignee and the securities with respect to which such registration rights are
being assigned; and provided, further, that such assignment shall be effective only
if immediately following such transfer the further disposition of such securities by the transferee
or assignee is restricted under the Securities Act. For the purposes of determining the number of
shares of Registrable Securities held by a transferee or assignee, the holdings of transferees and
assignees of a partnership who are partners or retired partners of such partnership (including
spouses and ancestors, lineal descendants and siblings of such partners or spouses who acquire
Registrable Securities by gift, will or intestate succession) shall be aggregated together and with
the partnership; provided that all assignees and transferees who would not qualify
individually for assignment of registration rights shall have a single attorney-in-fact for the
purpose of exercising any rights, receiving notices or taking any action under Section 1.




          1.13 Limitations on Subsequent Registration Rights. From and after the date of this
Agreement, the Company shall not, without the prior written consent of the Holders of a majority of
the outstanding Registrable Securities (except as otherwise provided in Section 4.2 hereof), enter
into any agreement with any holder or prospective holder of any securities of the Company which
would allow such holder or prospective holder (a) to include such securities in any registration
filed under Section 1.2 hereof, unless under the terms of such agreement, such holder or
prospective holder may include such securities in any such registration only to the extent that the
inclusion of his securities will not reduce the amount of the Registrable Securities of the Holders
which is included or (b) to make a demand for registration of such securities.




          1.14 “Market Stand-Off” Agreement. Each Holder, Founder, Investor and Common
Shareholder (collectively, the “Shareholders”) hereby agrees that, during the period of
duration (up to, but not exceeding, 180 days) specified by the Company and an underwriter of Common
Stock or other securities of the Company, following the effective date of a registration statement
of the Company filed under the Securities Act, it shall not, to the extent requested by the Company
and such underwriter, directly or indirectly sell, offer to sell, contract to sell (including,
without limitation, any short sale), grant any option to purchase or otherwise transfer or dispose
of (other than to donees who agree to be similarly bound) any securities of the Company held by it
at any time during such period except Common Stock included in such registration; provided,
however, that:




               (a) such agreement shall be applicable only to the first such registration statement of the
Company which covers Common Stock (or other securities) to be sold on its behalf to the public in
an underwritten offering; and



               (b) all officers and directors of the Company, all one-percent or greater securityholders, and
all other persons with registration rights (whether or not pursuant to this Agreement) enter into
similar agreements.



-12-









 





          In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions
with respect to the Registrable Securities of each Shareholder (and the shares or securities of
every other person subject to the foregoing restriction) until the end of such period, and each
Shareholder agrees that, if so requested, such Shareholder will execute an agreement in the form
provided by the underwriter containing terms which are essentially consistent with the provisions
of this Section 1.14.




          Notwithstanding the foregoing, the obligations described in this Section 1.14 shall not apply
to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar
forms which may be promulgated in the future, or a registration relating solely to an SEC Rule 145
transaction on Form S-4 or similar forms which may be promulgated in the future.




          1.15 Termination of Registration Rights. No Holder shall be entitled to exercise any
right provided for in this Section 1 after the earlier of (i) five (5) years following the
consummation of a Qualified IPO, or (ii) such time as Rule 144 or another similar exemption under
the Securities Act is available for the sale of all of such Holder’s shares during a consecutive
three (3)-month period without registration.




     2. Covenants of the Company.



          2.1 Delivery of Financial Statements. The Company shall deliver to each Holder of at
least 200,000 shares of Registrable Securities (other than a Holder reasonably deemed by the
Company to be a competitor of the Company):




               (a) as soon as practicable, but in any event within ninety (90) days after the end of each
fiscal year of the Company, an income statement for such fiscal year, a balance sheet of the
Company and statement of shareholder’s equity as of the end of such year, and a statement of cash
flows for such year, such year-end financial reports to be in reasonable detail, prepared in
accordance with generally accepted accounting principles (“GAAP”), and audited and
certified by an independent public accounting firm of nationally recognized standing selected by
the Company;



               (b) as soon as practicable, but in any event within forty-five (45) days after the end of each
of the first three (3) quarters of each fiscal year of the Company, an unaudited profit or loss
statement, a statement of cash flows for such fiscal quarter and an unaudited balance sheet as of
the end of such fiscal quarter; and



               (d) as soon as practicable, but in any event thirty (30) days prior to the end of each fiscal
year, a budget and business plan for the next fiscal year, prepared on a quarterly basis, and, as soon as prepared, any other budgets or revised budgets prepared by
the Company.



          2.2 Inspection. The Company shall permit each Holder of at least 200,000 shares of
Registrable Securities (except for a Holder reasonably deemed by the Company to be a





-13-









 







competitor of the Company), at such Holder’s expense, to visit and inspect the Company’s properties, to examine
its books of account and records and to discuss the Company’s affairs, finances and accounts with
its officers, all at such reasonable times as may be requested by the Investor; provided,
however, that the Company shall not be obligated pursuant to this Section 2.2 to provide
access to any information which it reasonably considers to be a trade secret or similar
confidential information.




          2.3 Right of First Offer. Subject to the terms and conditions specified in this
Section 2.3, the Company hereby grants to each Major Investor (as hereinafter defined) a right of
first offer with respect to future sales by the Company of its Shares (as hereinafter defined).
For purposes of this Section 2.3, a “Major Investor” shall mean any person who holds at
least 200,000 shares of Series B, Series C, Series D and/or Series E Preferred Stock (or Common
Stock issued upon conversion of such shares of Series B, Series C, Series D and/or Series E
Preferred Stock), as adjusted for stock dividends, stock splits, reclassifications and the like.
For purposes of this Section 2.3, Major Investor includes any general partners and affiliates of a
Major Investor. A Major Investor that chooses to exercise the right of first offer may designate
as purchasers under such right itself or its partners or affiliates in such proportions as it deems
appropriate.




          Each time the Company proposes to offer any shares of, or securities convertible into or
exercisable for any shares of, any class of its capital stock (for purposes of this Section 2.3,
the “Shares”), the Company shall first make an offering of such Shares to each Major
Investor in accordance with the following provisions:




               (a) The Company shall deliver a notice by certified mail (“Notice”) to the Major
Investors stating (i) its bona fide intention to offer such Shares, (ii) the number of such Shares
to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such Shares.



               (b) Within 15 calendar days after delivery of the Notice, the Major Investor may elect to
purchase or obtain, at the price and on the terms specified in the Notice, up to that portion of
such Shares which equals the proportion that the number of shares of Common Stock issued and held,
or issuable upon conversion and exercise of all convertible or exercisable securities then held, by
such Major Investor bears to the total number of shares of Common Stock then outstanding (assuming
full conversion and exercise of all convertible securities, warrants or options). The Company
shall promptly, in writing, inform each Major Investor that purchases all the shares available to
it (each, a “Fully-Exercising Investor”) of any other Major Investor’s failure to do
likewise. During the ten (10)-day period commencing after receipt of such information, each Fully-Exercising Investor shall be entitled to obtain that portion of
the Shares for which Major Investors were entitled to subscribe but which were not subscribed for
by the Major Investors that is equal to the proportion that the number of shares of Common Stock
issued and held, or issuable upon conversion and exercise of all convertible or exercisable
securities then held, by such Fully-Exercising Investor bears to the total number of shares of
Common Stock then outstanding (assuming full conversion and exercise of all convertible or
exercisable securities, warrants or options).



-14-









 





               (c) The Company may, during the 45-day period following the expiration of the period provided
in subsection 2.3(b) hereof, offer the remaining unsubscribed portion of the Shares to any person
or persons at a price not less than, and upon terms no more favorable to the offeree than those
specified in the Notice. If the Company does not enter into an agreement for the sale of the
Shares within such period, or if such agreement is not consummated within 60 days of the execution
thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be
offered unless first reoffered to the Major Investors in accordance herewith.



               (d) The right of first offer in this paragraph 2.3 shall not be applicable (i) to the issuance
or sale of shares of Common Stock (or options therefor) to employees, officers, consultants and
directors, vendors or others with whom the Company conducts business pursuant to a stock option
plan or restricted stock plan approved by the Board of Directors for the primary purpose of
soliciting or retaining their services, (ii) to or after consummation of a Qualified IPO, (iii) to
the issuance of securities pursuant to the conversion or exercise of convertible or exercisable
securities, (iv) to the issuance of securities in connection with a bona fide business acquisition
of or by the Company, whether by merger, consolidation, sale of assets, sale or exchange of stock
or otherwise, or similar transaction, the terms of which are approved by the Board of Directors of
the Company, (v) to the issuance of securities to financial institutions or lessors in connection
with commercial credit arrangements, equipment financings, or similar transactions, or that are for
other than primarily equity financing purposes, (vi) to the issuance or sale of the Series E
Preferred Stock or warrants to purchase the Series E Preferred Stock, (vii) to the issuance of
securities that, with unanimous approval of the Board of Directors of the Company, are not offered
to any existing shareholder of the Company, or (viii) to the issuance of securities in connection
with a transaction approved by the Board of Directors of the Company to an entity as a component of
a business relationship with such entity also involving material manufacturing, marketing,
distribution, product development and/or technology licensing arrangements. In addition to the
foregoing, the right of first offer in this paragraph 2.3 shall not be applicable with respect to
any Investor and any subsequent securities issuance, if (i) at the time of such subsequent
securities issuance, the Investor is not an “accredited investor,” as that term is then defined in
Rule 501(a) under the Securities Act, and (ii) such subsequent securities issuance is otherwise
being offered only to accredited investors.



          2.4 Termination of Covenants.




               (a) The covenants set forth in Sections 2.1 through Section 2.3 shall terminate as to each
Holder and be of no further force or effect (i) immediately prior to the
closing of a Qualified IPO, or (ii) when the Company shall sell, convey, or otherwise dispose
of or encumber all or substantially all of its property or business or merge into or consolidate
with any other corporation (other than a wholly-owned subsidiary corporation) or effect any other
transaction or series of related transactions in which more than fifty percent (50%) of the voting
power of the Company is disposed of, provided that this subsection (ii) shall not apply to
a merger effected exclusively for the purpose of changing the domicile of the Corporation.



               (b) The covenants set forth in Sections 2.1 and 2.2 shall terminate as to each Holder and be
of no further force or effect when the Company first becomes subject to



-15-









 




the periodic reporting requirements of Sections 13 or 15(d) of the Exchange Act, if this occurs earlier than the events
described in Section 2.4(a).




     3. Restrictions on Transfer.



          3.1 Notice of Sales; Right of First Refusal.




               (a) Should any Shareholder propose to accept one or more bona fide offers (collectively, a
“Purchase Offer”) from any person(s) or entity(ies) to purchase any shares of the Company’s
capital stock or portions thereof held by such Shareholder (for purposes of this Section 3, the
“Shares”) (other than as set forth in Section 3.4 hereof), such Shareholder shall promptly
deliver a notice (the “Notice”) to the Company stating the terms and conditions of such
Purchase Offer including, without limitation, the number of shares of the Company’s capital stock
to be sold or transferred, the nature of such sale or transfer, the consideration to be paid, and
the name and address of each prospective purchaser or transferee. The Company shall then have the
right, exercisable by notice to the selling Shareholder within thirty (30) days after receipt of
the Notice (the “Initial Company Refusal Period”), to exercise a first right to purchase
all or a portion of such Shares (the “Initial Company Right of First Refusal”) on the same
terms and conditions as described in the Notice.



               (b) If the Company does not exercise the Initial Company Right of First Refusal in full and
the sale of the Shares by such Shareholder has been approved by a two-thirds majority of the Board
of Directors of the Company pursuant to Section 3.3 hereof, then promptly after the expiration of
the Initial Company Refusal Period, the Company shall send a written notice, which notice shall
include the Notice from the selling Shareholder (together the “Second Notice”), to each
Investor stating that the Company has chosen not to exercise, in full or in part, the Initial
Company Right of First Refusal. The Company shall then have the right, exercisable by notice to
the selling Shareholder within thirty (30) days after the date of the Second Notice (the
“Subsequent Company Refusal Period”), to exercise a first right to purchase all or a
portion of such Shares (the “Subsequent Company Right of First Refusal”) on the same terms
and conditions as described in the Notice. Each Investor shall have the secondary right, subject
to the Subsequent Company Right of First Refusal, exercisable by notice to the selling Shareholder
and to the Company within twenty (20) days after the Second Notice (the “Refusal Period”),
to exercise a right to purchase such Shares not purchased by the Company (the “Right of First
Refusal”) on the same terms and conditions as described in the Notice and on a pro rata basis,
based upon the number of shares of Common Stock issued and held, or issuable upon
conversion and exercise of all convertible or exercisable securities then held, by such
Investor relative to the aggregate number of shares of Common Stock issued and held, or issuable
upon conversion and exercise of all convertible or exercisable securities then held, by all
Investors; provided that if fewer than all Investors elect to participate, the Shares that
would otherwise be allocated to non-participating Investors shall be allocated to each
participating Investor in a manner such that each participating Investor is entitled to purchase at
least such Investor’s pro rata portion of such unallocated or such different number of Shares as
the participating Investors shall mutually agree. Upon expiration of the Subsequent Company
Refusal Period, the Company will provide notice to all Investors as to whether or not the
Subsequent Company Right of First



-16-









 




Refusal has been exercised by the Company, and to the extent that it has not, as to whether or not the Right of First Refusal has been exercised by one or more of
the Investors.




          3.2 Failure to Exercise. The failure by the Company or an Investor to exercise the
rights under Section 3.1 or Section 3.3 to purchase any portion of Shares in a sale of Shares made
by a Shareholder shall not affect the Company’s or such Investor’s rights to purchase any portion
of Shares in subsequent sales of Shares by any Shareholder.




          3.3 No Transfers without Board Approval. Except for transfers to the Company pursuant
to Section 3.1 and except as permitted pursuant to Section 3.4, no Shareholder may transfer any
shares of capital stock of the Company (including without limitation to Investors pursuant to
Section 3.1(b)) without first obtaining the written consent to such transfer from a two-thirds
majority of the Company’s Board of Directors, such two-thirds majority in its good faith judgment,
having determined that such transfer would not be detrimental to the interests of the Company and
its shareholders. In addition, as a condition precedent to any such transfer, the transferee must
agree in writing to be bound by the terms of this Section 3.3 as if such transferee were a
Shareholder under this Section 3.3, and to be bound by all other provisions of this Agreement
applicable to the transferor.




          3.4 Permitted Transactions. The provisions of Section 3.1 and Section 3.3 of this
Agreement shall not pertain or apply to:




               (a) any pledge of the Company’s capital stock made by a Shareholder pursuant to a bona fide
loan transaction which creates a mere security interest;



               (b) any bona fide gift;



               (c) any transfer to a Shareholder’s ancestors, descendants or spouse or to a trust for their
benefit;



               (d) any sale or transfer of shares of Common Stock among the Shareholders;



               (e) any sale or transfer by a Shareholder of up to 5% of the total number of shares of Common
Stock held by such Shareholder on the date of this Agreement in
any twelve-month period; provided that the pledgee, transferee or donee (collectively,
the “Permitted Transferees”) shall furnish the other Shareholders with a written agreement
to be bound by and comply with all provisions of this Agreement applicable to the Shareholders; or



               (f) any transfer by a Shareholder that is a partnership to a partner of such partnership or a
retired partner of such partnership who retires after the date hereof, or to the estate of any such
partner or retired partner or the transfer by gift, will or intestate succession of any partner to
his or her spouse or to the siblings, lineal descendants or ancestors of such partner or his or her
spouse.



-17-









 





          3.5 Prohibited Transfers. Any attempt by a Shareholder to transfer shares of the
Company in violation of Section 3 hereof shall be void, and the Company agrees it will not effect
such a transfer nor will it treat any alleged transferee as the holder of such shares without the
written consent of the holders of a two-thirds majority of the Shareholders, voting as a single
class on a fully diluted, as-converted basis, and the written consent of a two-thirds majority of
the Board of Directors of the Company.




          3.6 Legended Certificates. Each certificate representing shares of the Series A,
Series B, Series C, Series D and Series E Preferred Stock and Common Stock now owned by the
Shareholders or issued to any Permitted Transferee pursuant to Section 3.4 shall bear the following
legend:





“THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS
CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN RESTRICTIONS
AGREEMENT BY AND BETWEEN THE SHAREHOLDER, THE CORPORATION AND CERTAIN HOLDERS OF
COMMON AND PREFERRED STOCK OF THE CORPORATION. COPIES OF SUCH AGREEMENT MAY BE
OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.”



     The foregoing legend shall be removed upon termination of this Agreement in accordance with
the provisions of Section 3.7.



          3.7 Termination. The obligations and restrictions contained in this Section 3 shall
terminate upon the earliest to occur of any one of the following events (and shall not apply to any
transfer by a Shareholder in connection with any such event):




               (a) the liquidation, dissolution or indefinite cessation of the business operations of the
Company;



               (b) the execution by the Company of a general assignment for the benefit of creditors or the
appointment of a receiver or trustee to take possession of the property and assets of the Company;



               (c) the consummation of a Qualified IPO; or



               (d) the sale, conveyance, disposal, or encumbrance of all or substantially all of the
Company’s property or business or the Company’s merger into or consolidation with any other
corporation (other than a wholly-owned subsidiary corporation) or if the Company effects any other
transaction or series of related transactions in which more than fifty percent (50%) of the voting
power of the Company is disposed of; provided that this Section 3.7(d) shall not apply to a
merger effected exclusively for the purpose of changing the domicile of the Company.



-18-









 





     4. Miscellaneous.



          4.1 Successors and Assigns. Except as otherwise provided in this Agreement, the terms
and conditions of this Agreement shall inure to the benefit of and be binding upon the respective
permitted successors and assigns of the parties (including transferees of any of the Preferred
Stock or any Common Stock issued upon conversion thereof). Nothing in this Agreement, express or
implied, is intended to confer upon any party other than the parties hereto or their respective
successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement.




          4.2 Amendments and Waivers. Any term of this Agreement may be amended or waived only
with the written consent of the Company and the holders of a majority of the Registrable Securities
then outstanding, not including the Founders’ Stock; provided that if such amendment has
the effect of affecting the Founders’ Stock (i) in a manner different than securities issued to the
Investors and (ii) in a manner adverse to the interests of the holders of the Founders’ Stock, then
such amendment shall require the consent of the holder or holders of a majority of the Founders’
Stock. Notwithstanding the foregoing, subsequent Purchasers (as defined under the Purchase
Agreement) of the Company’s Series E Preferred Stock under the Purchase Agreement or any Addendum
Agreement thereto will be added as a party to this Agreement as an Investor without having to
obtain the consents set forth above and shall be bound by and entitled to the terms, benefits and
conditions herein by the execution and delivery of a signature page to this Agreement. Any
amendment or waiver effected in accordance with this paragraph shall be binding upon each holder of
any Registrable Securities then outstanding, each future holder of all such Registrable Securities,
and the Company.




          4.3 Notices. Unless otherwise provided, any notice required or permitted by this
Agreement shall be in writing and shall be deemed sufficient upon delivery, when delivered
personally or by overnight courier or sent by telegram or fax with electronic confirmation
received, or forty-eight (48) hours after being deposited in the U.S. mail, as certified or
registered mail, with postage prepaid, and addressed to the party to be notified at such party’s
address or fax number as set forth on the signature page or Exhibits hereto or as subsequently
modified by written notice.




          4.4 Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, the parties agree to renegotiate such provision in good faith.
In the event that the parties cannot reach a mutually agreeable and enforceable replacement for
such provision, then (a) such provision shall be excluded from this Agreement, (b) the balance of
this Agreement shall be interpreted as if such provision were so excluded and (c) the balance of
this Agreement shall be enforceable in accordance with its terms.




-19-









 








          4.5 Governing Law. This Agreement and all acts and transactions pursuant hereto shall
be governed, construed and interpreted in accordance with the laws of the State of Washington,
without giving effect to principles of conflicts of laws.




          4.6 Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.




          4.7 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.




          4.8 Aggregation of Stock. All shares of the Preferred Stock held or acquired by
affiliated entities or persons shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement.




          4.9 Entire Agreement. This Agreement (including the Exhibits hereto, if any)
constitutes the entire understanding among the parties with regard to the subjects hereof and
thereof.




          4.10 Telecopy Execution and Delivery. A facsimile, telecopy or other reproduction of
this Agreement may be executed by one or more parties hereto, and an executed copy of this
Agreement may be delivered by one or more parties hereto by facsimile or similar electronic
transmission device pursuant to which the signature of or on behalf of such party can be seen, and
such execution and delivery shall be considered valid, binding and effective for all purposes. At
the request of any party hereto, all parties hereto agree to execute an original of this Agreement
as well as any facsimile, telecopy or other reproduction hereof.




          4.11 Arbitration. The parties agree to attempt in good faith to negotiate a
settlement of any and all controversies, claims, or disputes arising out of, relating to, or
resulting from this Agreement. If, after such good faith negotiation, the parties are not able to
reach a settlement, any and all of such controversies, claims, or disputes arising out of, relating
to, or resulting from this Agreement shall be subject to binding arbitration. Such arbitration
shall take place in Seattle, Washington and will be administered by the American Arbitration Association
(“AAA”) in accordance with its Rules for the Resolution of Commercial Disputes. The
parties agree that the arbitrator shall have the power to decide any motions brought by any party
to the arbitration, including motions for summary judgment and/or adjudication and motions to
dismiss and demurrers, prior to any arbitration hearing. The parties also agree that the
arbitrator shall have the power to award any remedies, including attorneys’ fees and costs,
available under applicable law, provided that the prevailing party in any arbitration shall be
entitled to its reasonable attorneys fees and costs. The decision of the arbitrator shall be in
writing.






-20-









 







Arbitration shall be the sole, exclusive and final remedy for any dispute under this
Agreement and the decision of the arbitrator may be entered by a party in any court or forum, state
or federal, being of competent jurisdiction. Accordingly, no party will be permitted to pursue
court action regarding this Agreement except as expressly permitted in the preceding sentence.
Notwithstanding the foregoing, each party retains the right to seek injunctive relief to prevent a
breach, threatened breach or continuing breach of this Agreement that would cause irreparable
injury to such party.




          4.12 Termination and Supersession. This Agreement replaces and supersedes the Prior
Agreement, and the Prior Agreement is hereby terminated.




[Signature Page Follows]





-21-











 





     The parties have executed this Amended and Restated Investors’ Rights Agreement as of the date
first above written.



	 	 	 	 	 
	 	COMPANY:





OMEROS CORPORATION

 	 
	 	By:  	/s/ Gregory A. Demopulos	 
	 	 	Gregory A. Demopulos, M.D. 	 
	 	 	Chairman of the Board, President and

Chief Executive Officer




Address:      1420 Fifth Ave., Suite 2600
Seattle, WA  98101



Fax:  (206) 264-7856 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT





 









 








	 	 	 	 	 
	 	SERIES E INVESTOR:

 	 
	 	
 	 
	 	(Investor) 	 
	 	 	 
	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	 	(print)	 
	 	 	Title:  	 	 
	 	 	 	(if applicable)	 
	 	 	Address:  	 	 
	 
	 	 	Fax:  	 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT





 









 








	 	 	 	 	 
	 	FOUNDERS:

 	 
	 	
 	 
	 	H. Raymond Cairncross 	 
	 
	 	Address:





Fax: 	 
	 
	 	 	 
	 	/s/ Gregory A. Demopulos	 
	 	Gregory A. Demopulos, M.D. 	 
	 
	 	Address:




Fax: 	 
	 
	 	 	 
	 	
 	 
	 	George Kargianis 	 
	 
	 	Address:





Fax: 	 
	 
	 	 	 
	 	
 	 
	 	Pamela Pierce Palmer, M.D., Ph.D. 	 
	 
	 	Address:




Fax: 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT





 









 








	 	 	 	 	 
	 	SERIES A INVESTOR:

 	 
	 	
 	 
	 	(Investor) 	 
	 	 	 
	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	 	(print)	 
	 	 	Title:  	 	 
	 	 	 	 	 
	 	 	Address:  	 	 
	 
	 	 	Fax:  	 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT





 









 








	 	 	 	 	 
	 	SERIES B INVESTOR:

 	 
	 	
 	 
	 	(Investor) 	 
	 	 	 
	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	 	(print)	 
	 	 	Title:  	 	 
	 	 	 	 	 
	 	 	Address:  	 	 
	 
	 	 	Fax:  	 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT




 









 








	 	 	 	 	 
	 	SERIES C INVESTOR:

 	 
	 	
 	 
	 	(Investor) 	 
	 	 	 
	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	 	(print)	 
	 	 	Title:  	 	 
	 	 	 	 	 
	 	 	Address:  	 	 
	 
	 	 	Fax:  	 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT





 









 








	 	 	 	 	 
	 	SERIES D INVESTOR:

 	 
	 	
 	 
	 	(Investor) 	 
	 	 	 
	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	 	(print)	 
	 	 	Title:  	 	 
	 	 	 	 	 
	 	 	Address:  	 	 
	 
	 	 	Fax:  	 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT





 









 








	 	 	 	 	 
	 	COMMON SHAREHOLDER:

 	 
	 	/s/ Gregory A. Demopulos	 
	 	(Common Shareholder) 	 
	 	 	 
	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	 	(print)	 
	 	 	Title:  	 	 
	 	 	 	 	 
	 	 	Address:  	 	 
	 
	 	 	Fax:  	 	 
	 



SIGNATURE PAGE TO OMEROS CORPORATION’S

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT





 











 





Exhibit A




SERIES E INVESTORS




Marie Stanislaw and Steve Abel




Charles L. Anderson




Dean E. and Lynda M. Anderson JTWROS




Richard W. Anderson




Charles C. Andonian




Andonian Family GST Trust




Martin Andrews




Robert M. Arnold




William and Sylvia Bailey




David H. and Jean Barber




Larry L. Barokas




Alan Bartelheimer




Robert and Alice Bender




Thad Berger




William Blum




Stephen K. Boone




BPEF 2 Omeros Partners, LP




Harold D. Brown




Frederick S. & Jane H. Buckner




Christine Buecker IRA Charles Schwab & Co., Inc. Cust.




John Burgess




 









 





Mark Callaghan




Cheve Famille LLC




Chicago Private Investments, Inc.




Ching Defined Benefit Pension Plan




Ching Revocable Trust




Jeff & Janee Christianson




Delores Christianson




Ivan Christianson




CIBC Trust Company (Bahamas) Limited as Trustee of T-2100




Alan and Margaret Cornell




Dale E. Cowles




Bennett and Shirley LaFollette Cozadd




R. Michael Creighton




Critchfield Investment Partners, L.P.




Brian Crynes




Robert Curley




Jann Curley




Michael and Martha Davidson




Harold L. and Pride E. Davies




Patrick Day




M.R. de Carvalho




Delaware Charter Guarantee & Trust Co., Trustee FBO, Jeff Esfeld/Roth IRA




Dennis Shay Co. Profit Sharing Trust




Moss Adams LLP DEF BEN PEN PL #95 U/A DTD 1/31/89, Edward C. Drosdick, TTEE




 









 





Richard R. and Marilyn B. Dunn




Richard M. Elkus




Steven and Pauline Elliott




Kevin Elliott




Ruth and John Fay




Robert Feldman




First Washington PSP, DTD 7/1/84 FBO Philip F. Frank Jr., Philip F. Frank Jr. Trustee




Drew & Kristin Fletcher




Barbara R. and Robert M. Frayn, Jr.




Frederick Goldberg Family, LLC




Stuart Fuchs IRA




Gary and Della Furukawa




Michael Gano




Eduardo Garcia & Jane Hoerig




Gretchen Garth




Bill and Lindy Gaylord




Gregory and Susan George




Jonathan R. Goldner




Dian Goldberg




Frederick Goldberg




Stanley and Carolyn Graves




Grosvenor Special Ventures IV, LP




Frank B. & Joan Hall




Scott & Kerry Hall




 









 





Bradley Harris




Tom and Jo Ann R. Hornsten




Arthur and Janet Stanton Hurd




Peter Indelicato




Walter R. Ingram




Sam and Naomi Israel




Donald M. Jasper




Donald and Beverly Jefferson




Scott and Susan Jennings




JLB Investment Company




Kanter Family Foundation (IL Corp.)




Gloria Katz Revocable Trust




Bruce Keithly IRA Charles Schwab & Co., Inc. Cust.




David Kenyon




Edward B. Kibble




Donald E. Kline




Robert Kollack




Koppes Family Revocable Trust, Alan W. Koppes Trustee




Dennis J. Kvidera




Kvidera Living Trust




Henry Liebman




Rex Lund




Louis Lundquist




Kathy Lusher




 









 





Chai Mann




Pamela B McCabe




Patrick and Michele McCarthy




Karen McDonald




Susan Melodia




Lawrence Meurk




Joanne K. Meyers




Randee Sue Meyers




Michael C. Mossman




MST Partners




Douglas Norberg




Novel BioVentures LLC




Richard J. and Vonda M. Olson




B. Delores O’Neil




Thomas Orvald




James Osgood




Donald F. Padelford




Christohper G Pallis




Chris N Pallis




Christopher G. Pallis IRA




Vasillios N. Pallis




Patricia L. Pedegana




Donald & Laura Peterson Petersen, JTWROS




Donald E. Petersen




 









 





Brent P. Pistorese and Linda D. Pistorese Revocable Living Trust




Hasso Plattner




Kathleen Popham




Prentice Family Partnership




Prime Time Partners, L.P.




Prime Time Partners




Herbert Pruzan




Harry Pryde




Paul A. Raidna




Peter and Debra Rettman




George Reynolds




Bradley G. Rich




Ring Revocable Trust, Lawrence W. Ring, Trustee




R.E. Rohde




Dan Rome




John C. Rosling




Donn Rowe




John and Linda Schukar




George E.S. Seligman




Steven L. Sherman




Sherwood Associates, LLC




Lorraine Smith




Linda Barker Spear




John M. Spicer




 









 





Robert H and Rita A. Splan




Greg and Vicky Stamolis




Chris W. Strand IRA Rollover UTA Charles Schwab & Co. Inc.




Joseph P. & D. Dyann Strecker




Stuart Sulman




Scott Sulman




Summit Capital Partners, L.P.




Michael J Swindling




Janet Taggares




Tenwall Investment Co.




Brad Thompson




Richard Toll




Wells Fargo Bank IRA C/F Richard W. Tschetter




Gregory P. Vernon




Trevor Vernon




Jerome K. Walsh




Stephen J. Warner




Washington Research Foundation




Gary Waterman




Bruce E. Watterson




Michael Weaver




Jon D. Wheeler




Brad Williamson




Charlotte Witter




 









 





Malcolm G. Witter IRA/Bear Stearns Custodian




Olivia Witter




 









 





Exhibit B




SERIES A INVESTORS




Gary R. and Mitzi M. Aspiri




Aspiri Enterprises LLC




Jon A. and Julie P. Barwick




Thomas W. and Ann M. Barwick




David and Virginia Broudy




Thomas J. Cable Defined Benefit Retirement Plan




Larry W. and Mary K. Crocker, JTWROS




Peter A. Demopulos, M.D.




Milton and Nancy English




Barbara R. and Robert M. Frayn, Jr.




Steven and Anne Gillis, JTWROS




E. Cary Halpin D.D.S., P.S.

Profit Sharing Plan




Chauncey F. Lufkin




Chauncey F. Lufkin, as trustee for

Wende Lufkin




Chauncey F. Lufkin, as trustee for

Lisa L. Collins




Chauncey F. Lufkin, as trustee for

Chauncey F. Lufkin, Jr.




Chauncey F. Lufkin, as trustee for

Andrew Lufkin




Chris G. and Vasiliki L. Pallis




Harry Pryde




 









 





Wayne E. Quinton




William J. Rex




T2G Limited Partnership




 









 





Exhibit C




SERIES B INVESTORS




Charles L. Anderson




Travis S. Ashby




Aspiri Enterprises LLC




Milton A. Barrett, Jr. and Jane S. Barrett




Andrew J. Berndt




Bost & Co. FBO Leonard A. Yerkes




John M. Brenneman




Susan E. Brock-Utne




Thomas F. and Joyce S. Broderick




Thomas J. Cable




City National Bank

TTEE FBO DWT/James




City National Bank Bank Trustee

DWT FBO Bruce Lamka




Dale E. Cowles




Critchfield Investment Partners, L.P.




Thomas E. Doelger




George T. Drugas, M.D. & Heidi J. Drugas




Peter W. Eising




Ruth G. Fleischmann




Francis D. Galey




Gretchen Garth




William H. Gates, Jr.




 









 





Jerry L. and Mary E. Gatewood




Jonathan R. Goldner




Joshua Starbuck Goldner




Marcia M. Goldner




Steven Goldner

As custodian for Julia Starbuck Goldner




Steven Craig Goldner




Dan M. and Wendy Ershig Guy III




Frank B. and Joan B. Hall




Scott and Kerry Hall




Patrick M. and Melinda G. Hannigan




Tom and JoAnn Hornsten




Donn and Abigail Hutchins




Barbara Olivia Jackson




Blayne Johnson




David Kenyon




Edward R. Kibble




Scott Land




Captain Thomas Latsoudis




Chauncey F. Lufkin




Rex Lund




Pamela B. McCabe




Craig McCallum




Daniel J. McHugh




Patricia A. Milbank




 









 





Patrick R. Milbank




MST Partners — Leonard H. Shapiro




Dallas L. Otter




Carol F. Padelford




Chris G. and Vasiliki L. Pallis




Panos Brothers Capital, LLC




Patricia L. Pedegana




Piper Jaffray, Inc. as custodian for the benefit of (FBO)

John Hopkins




Arlen I. Prentice




David Prentice




Quarry Capital Corporation




Paul A. Raidna




Robert J. and Terri L. Rusch, Jr.




John B. Scates




Craig E. Sherman




A.G. Edwards & Sons, Inc. Custodian for Daniel A. Sherman, M.D.,

FBO Daniel A. Sherman M.D. Profit Sharing Plan




Vicki L. Sheron




Christopher F. Smith




Gary B. and Marilyn R. Smith




Beth Starbuck




Craig W. and Valerie A. Stewart




STF III, L.P.




Joseph P. Strecker and D. Dyann Strecker




 









 





Paul and Mary Elizabeth Stritmatter




A.L. and Lucy J. Sytman




T2G Limited Partnership




David R. Toll




Trans Cosmos USA, Inc.




TTEE Robert W. Bethke Living Trust U/A DTD August 22, 1986




VLG Investments 1998




Wayne C. Wager




Christian Wedell




Malcolm G. Witter




Robert L. and Valerie R. Yurina




 









 





Exhibit D




SERIES C INVESTORS




Douglas D. Adkins




Alchemy Partners, LLC




Charles L. Anderson




Richard W. Anderson




Travis Ashby




Aspiri Enterprises LLC




Milton A. Barrett, Jr. and Jane S. Barrett




Roger C. Berger, Marital Trust




Andrew J. Berndt




John Brenneman




Deborah Brunton




Frederick S. and Jane H. Buckner




Thomas J. Cable




Ivan and Delores Christianson




Jeff and Janee Christianson




CIBC World Markets as custodian for

Dr. Lynn Staheli IRA




Reed Corry




Dale L. Cowles




Critchfield Investment Partners, L.P.




CSK-4 Investment Fund




Dean Witter Reynolds custodian for

Marianne LoGerfo IRA Standard




 









 





Delphic Navigation Company Limited




Thomas E. Doelger




Chris T. Economou




Ershig Family Ltd. Partnership




Ruth G. Fleischmann




Drew and Kristin Fletcher




Edward D. Fugo, Jr.




John Gerondis




James Giammatteo




Gary Glant




Jonathan Goldner




Marcia Goldner




Steven Goldner as custodian for

Joshua Goldner




Steven Goldner as custodian for

Julia Goldner




Thomas Green




Dan M. and Wendy Ershig Guy III




H&L Investment Company




Frank B. and Joan B. Hall




Scott and Kerry Hall




Charles K. Hanson




Leroy E. Hood, M.D., Ph.D.




Tom and JoAnn Hornsten




Grady Hughes




Donn and Abigail Hutchins




 









 





Bost & Co. FBO

Leonard A. Yerkes III




Itochu Finance Corporation




Barbara Olivia Jackson




Jerome M. Johnson




Makoto Kaneshiro




William T. Karr




John Keister




David Kenyon




Sanjeev Khanna




Edward B. Kibble




Pamela L. Kirkpatrick




Donald E. Kline




Larry Kopp




Bruce Lamka and Susan Duffy




The Lawrence Trust as dated Aug. 3, 1989,

as amended June 6, 1997 and Sept. 16, 1998




Michael Ludwig




Luna Capital LLC I




Pamela and Robert McCabe




Daniel J. McHugh




Marion Colby McNamara




Joanne K. Meyers




Mission Management and Trust FBO

Lawrence Ring IRA Account 7467




Robert H. Monroe




 









 





MST Partners — Leonard H. Shapiro




Richard J. and Vonda Olson




Gary Oppenheim




PAC Partnership




Carol F. Padelford




Donald F. Padelford




Chris Pallis




Patricia L. Pedegana




Donald E. Petersen and Laura J. Peterson, JTWROS




David Pienkowski




Brent and Linda Pistorese




Prentice Family Partnership




George A. and Sara A. Reynolds




John B. Scates




Scott E. Scribner




Martin Selig




Steven L. and Judith F. Sherman




Vicki L. Sheron




Geoffrey B. Shilling




John M. Spicer




Robert H. Splan

Survivors Trust Dated 7/31/93




Craig W. Stewart




Craig W. and Valerie A. Stewart




Harry G. Stewart




 









 





STF III, L.P.




Joseph P. Strecker IRA 8566-1600




Joseph P. and D. Dyann Strecker




D. Dyann Strecker IRA 8566-1258




Steve and Lori Sweningson




Michael Swindling




Tranceka, LLC




Trans Cosmos USA, Inc.




Geoffrey P. and Judith K. Vernon




Joseph R. Vitulli




Bruce E. Watterson




Malcolm G. Witter




 









 





Exhibit E




SERIES D INVESTORS




Douglas D. Adkins




Richard W. Anderson




Aspiri Enterprises LLC




Thomas W. Barwick




Catherine K. Boshaw




Frederick S. and Jane H. Buckner




Richard and Sallie Burhans




Mark Callaghan




Nicole Chitnis




Jeff and Janee Christianson




Ivan and Delores Christianson




Reed Corry




Mary E. Drobka




Georgette Essad




Gretchen Fava




Drew and Kristin Fletcher




Robert M. Frayne, Jr. and Barbara R. Frayne




Francis D. Galey




Gary Glant




Eunice Kensinger Goldner




Eunice Kensinger Goldner as custodian for

Julia Starbuck Goldner under the UGMA




Marcia M. Goldner




 









 





Jonathan R. Goldner




Richard D. Goldner




Steven C. Goldner




Eunice Kensinger Goldner as custodian for

Joshua Starbuck Goldner under the UGMA




Dan M. and Wendy Ershig Guy, III




H&L Investment Company




David E. Hartman




John M. Hopkins




Tom R. Hornsten




Grady M. Hughes




Barbara Olivia Jackson




City National Bank Trustee FBO DWT/Thomas James




Donald M. Jasper




Donald S. and Beverly J. Jefferson JTWROS




Jerome M. Johnson




John Keister




Russell C. Keithly




Edward B. Kibble




Larry S. Kopp




Duane and Suzanne Koxlien




Bruce Lamka and Susan Duffy




Joanne K. Meyers




Michele K. McCarthy Revocable Trust

Michele McCarthy Trustee




Karen McDonald




 









 





Michael C. Mossman




MST Partners




Richard J. and Vonda M. Olson




Donald F. Padelford




Chris Pallis




Donald E. Petersen and Laura J. Peterson, JTWROS




David Pienkowski




Brent P. Piesterese and Linda D. Piesterese Revocable Living Trust




Arthur C. III and Kathleen Popham




Prentice Family Partnership




Paul A. Raidna




George A. and Sara A. Reynolds




Bradley G. Rich




John C. Rosling




George E.S. Seligman




Robert H. Splan Survivors Trust




Steven L. Sherman




Staheli, Inc., Profit Sharing Trustees: Lynn and Lana Staheli




Beth Starbuck




Joseph P. and D. Dyann Strecker




Summit Capital Partners, L.P.




Michael J. Swindling




Janet Taggares




Tranceka, LLC




J. Joseph Veranth Rollover IRA




 









 





Gregory P. Vernon




Trevor Vernon




Joseph R. Vitulli




Malcolm G. Witter




Robert L. and Valerie R. Yurina




 









 





Exhibit F




COMMON SHAREHOLDERS




Aspiri Enterprises LLC




Scott T. Bell*




John Brenneman




Thomas F. Broderick




H. Raymond Cairncross




H. Raymond Cairncross as Custodian for Caitlin D. Cairncross*




H. Raymond Cairncross as Custodian for Christian H. Cairncross*




Terrence I. Danysh




Gregory A. Demopulos, M.D.




William W. Ericson*




Demopulos Family Trust




Janet Garrow*




Joshua Gebhardt*




Gail E. Gillenwater*




John W. Hempelmann*




Jeffrey Herz*




George Kargianis*




Marcia S. Kelbon*




Craig T. Kobayashi*




Donald E. Marcy




James W. McGinity*




Allison and Todd McIntyre*




 









 





John McKay*




Mark Mooney*




Eoin O’Leary*




George Pallis*




Themio Pallis*




Pamela A. Pierce-Palmer, M.D., Ph.D.




J. Thomas Richardson*




Dawson Taylor*




David R. Toll




Tranceka, LLC




Daniel C. Vaughn*




Rachel A. Weiss*





 





			
	*	 	Shall not be deemed a Common Shareholder pursuant to this Agreement until such time as such person
or entity shall have executed a counterpart signature page to this Agreement.